Table 4 Subgroup analysis of hemodynamic outcomes between the two groups.
GA group (n = 12) | SA group (n = 18) | Median, mean, or proportion difference [95% CI] | P value | |
---|---|---|---|---|
Differences between max and baseline | ||||
ΔSBP (mmHg) | 77.5 [21.0–86.5] | 2.0 [− 4.0 to 6.0] | − 75.5 [− 85.5, − 19.0] | < 0.001 |
SBP increase > 20% | 9 (75.0%) | 0 (0.0%) | − 75.0% [− 91.1%, − 41.7%] | < 0.001 |
ΔDBP (mmHg) | 43.0 [17.5–55.5] | 3.0 [− 2.0 to 6.0] | − 40.0 [− 53.0, − 13.5] | < 0.001 |
ΔMBP (mmHg) | 56.0 [12.0–65.0] | 1.0 [− 1.0 to 10.0] | − 55.0 [− 65.0, − 9.0] | 0.001 |
ΔHR (beat per min) | 22.6 ± 19.9 | 3.5 ± 14.9 | − 19.1 [− 33.2, − 5.0] | 0.006 |
HRV before bladder hydrodistention | ||||
RMSSD (ms) | 11.4 [6.1–15.2] | 19.3 [13.2–29.4] | 7.9 [− 0.9, 20.5] | 0.080 |
SDNN (ms) | 10.2 [6.5–23.8] | 20.5 [15.2–32.8] | 10.3 [− 3.9, 23.3] | 0.285 |
LF/HF ratio | 2.5 [1.3–6.8] | 2.3 [0.5–12.8] | − 0.2 [− 5.1, 7.7] | 0.849 |
HRV after bladder hydrodistention | ||||
RMSSD (ms) | 9.7 [7.1–12.5] | 20.6 [15.1–44.7] | 10.9 [4.2, 34.9] | 0.010 |
SDNN (ms) | 13.7 [8.4–18.0] | 18.5 [11.8–38.3] | 4.9 [− 4.3, 26.9] | 0.238 |
LF/HF ratio | 2.4 [0.4–14.1] | 1.4 [0.4–3.5] | − 1.1 [− 13.2, 1.5] | 0.495 |